检索结果 - Christopher Dufton
- Showing 1 - 6 results of 6
-
1
-
2
-
3
-
4
ARIES‐3: Ambrisentan Therapy in a Diverse Population of Patients with Pulmonary Hypertension 由 David B. Badesch, Jeremy Feldman, Anne Keogh, Michael A. Mathier, Ronald J. Oudiz, Shelley Shapiro, Harrison W. Farber, Michael D. McGoon, Adaani Frost, Martine Allard, Darrin Despain, Christopher Dufton, Lewis J. Rubin
出版 2011Artigo -
5
Ambrisentan for the Treatment of Pulmonary Arterial Hypertension 由 Nazzareno Galiè, Horst Olschewski, Ronald J. Oudiz, Ferrán Torres, Adaani Frost, Hossein Ardeschir Ghofrani, David B. Badesch, Michael D. McGoon, Vallerie V. McLaughlin, Ellen B. Roecker, Michael J. Gerber, Christopher Dufton, Brian L. Wiens, Lewis J. Rubin
出版 2008Artigo -
6
Orally Inhaled Flecainide for Conversion of Atrial Fibrillation to Sinus Rhythm 由 Jeremy N. Ruskin, A. John Camm, Christopher Dufton, Anderson C. Silva, Ype S. Tuininga, Erik Badings, Jonas S.S.G. de Jong, Thomas Oosterhof, Ismail Aksoy, Aaf F.M. Kuijper, Isabelle C. Van Gelder, Vincent F. van Dijk, Dieter Nuyens, Dirk Schellings, Mark Young Lee, Peter R. Kowey, Harry J.G.M. Crijns, Jean Maupas, Luiz Belardinelli
出版 2024Artigo
相关主题
Internal medicine
Medicine
Cardiology
Pulmonary hypertension
Randomized controlled trial
Alternative medicine
Ambrisentan
Bosentan
Clinical endpoint
Endothelin receptor
Environmental health
Heart failure
Pathology
Placebo
Population
Receptor
Adverse effect
Anatomy
Antisense RNA
Atrial fibrillation
Biology
Brain natriuretic peptide
Cancer research
Cell biology
Clinical trial
Cranial neural crest
Crest
Disease
Embryo
Embryogenesis